Your browser doesn't support javascript.
loading
Implementing two-stage consent pathway in neonatal trials.
Mitchell, Eleanor; Oddie, Sam J; Dorling, Jon; Gale, Chris; Johnson, Mark John; McGuire, William; Ojha, Shalini.
Afiliación
  • Mitchell E; Nottingham Clinical Trials Unit, School of Medicine, University of Nottingham, Nottingham, UK eleanor.mitchell@nottingham.ac.uk.
  • Oddie SJ; Department of Neonatal Medicine, Bradford Teaching Hospitals NHS Foundation Trust, West Yorkshire, UK.
  • Dorling J; Department of Neonatal Medicine, University Hospital Southampton NHS Foundation Trust, Southampton, UK.
  • Gale C; Neonatal Medicine, School of Public Health, Faculty of Medicine, Imperial College London, London, UK.
  • Johnson MJ; Department of Neonatal Medicine, University Hospital Southampton NHS Foundation Trust, Southampton, UK.
  • McGuire W; NIHR Southampton Biomedical Research Centre, University of Southampton and University Hospital Southampton NHS Foundation Trust, Southampton, UK.
  • Ojha S; Centre for Reviews and Dissemination, University of York, York, UK.
Arch Dis Child Fetal Neonatal Ed ; 108(1): 79-82, 2023 Jan.
Article en En | MEDLINE | ID: mdl-34949637
ABSTRACT
Perinatal trials sometimes require rapid recruitment processes to facilitate inclusion of participants when interventions are time-critical. A two-stage consent pathway has been used in some trials and is supported by national guidance. This pathway includes seeking oral assent for participation during the time-critical period followed by informed written consent later. This approach is being used in the fluids exclusively enteral from day one (FEED1) trial where participants need to be randomised within 3 hours of birth. There is some apprehension about approaching parents for participation via the oral assent pathway. The main reasons for this are consistent with previous research lack of a written record, lack of standardised information and unfamiliarity with the process. Here, we describe how the pathway has been implemented in the FEED1 trial and the steps the trial team have taken to support sites. We provide recommendations for future trials to consider if they are considering implementing a similar pathway. Trial registration number ISRCTN89654042.
Asunto(s)
Palabras clave

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Padres / Consentimiento Informado Tipo de estudio: Clinical_trials Límite: Female / Humans / Newborn / Pregnancy Idioma: En Revista: Arch Dis Child Fetal Neonatal Ed Asunto de la revista: PEDIATRIA / PERINATOLOGIA Año: 2023 Tipo del documento: Article País de afiliación: Reino Unido

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Padres / Consentimiento Informado Tipo de estudio: Clinical_trials Límite: Female / Humans / Newborn / Pregnancy Idioma: En Revista: Arch Dis Child Fetal Neonatal Ed Asunto de la revista: PEDIATRIA / PERINATOLOGIA Año: 2023 Tipo del documento: Article País de afiliación: Reino Unido